This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 7688-64-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
7688-64-4 / (19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl) acetate
Standard CAS: 7688-64-4
Multi CAS: Yes
Basic Information
copy
CAS
7688-64-4 copy
Multi CAS
Yes copy
Molecular Formula
C22H18N2O5 copy
Molecular Weight
390.400000 copy
Exact Mass
390.121572 copy
InChI
InChI=1S/C22H18N2O5/c1-3-22(29-12(2)25)16-9-18-19-14(8-13-6-4-5-7-17(13)23-19)10-24(18)20(26)15(16)11-28-21(22)27/h4-9H,3,10-11H2,1-2H3/t22-/m0/s1 copy
InChIKey
ASVIEXKOXDCZDF-QFIPXVFZSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
29 copy
Aromatic heavy atom count
16 copy
Fraction Csp3
0.27 copy
Rotatable bonds
2 copy
H-bond acceptors
7 copy
Molar refractivity
104.07 copy
TPSA
87.49 copy
LogP / Solubility
WLOGP
2.65 copy
MLOGP
2.36 copy
XLogP3
1.6 copy
Consensus LogP
2.2 copy
Log S (ESOL)
-4.21 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-4.67 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.64 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.22 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
4 copy